Core Insights - Rayonier Advanced Materials reported a revenue of $353 million for the quarter ended September 2025, reflecting a 12% decrease compared to the same period last year [1] - The company's EPS was -$0.07, an improvement from -$0.12 in the year-ago quarter, but did not meet the Zacks Consensus Estimate of -$0.07 [1][3] - The revenue fell short of the Zacks Consensus Estimate of $376.4 million by 6.22% [1] Revenue Performance - High-Yield Pulp revenue was $24 million, exceeding the average estimate of $21.15 million from two analysts [4] - Eliminations revenue was reported at -$7 million, slightly better than the estimated -$8 million [4] - Paperboard revenue was $39 million, below the average estimate of $48.45 million [4] EBITDA Analysis - EBITDA from operations for Paperboard was $1 million, significantly lower than the estimated $7.25 million [4] - Corporate EBITDA from operations was -$14 million, matching the average estimate [4] - High-Yield Pulp EBITDA from operations was -$9 million, worse than the estimated -$3.3 million [4] Stock Performance - Rayonier Advanced Materials shares have returned -13.1% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance against the broader market in the near term [3]

Financial Performance - Net sales for Q3 2025 were $353 million, down $48 million or 12% from the prior year quarter[6]. - Loss from continuing operations for Q3 2025 was $4 million, an improvement of $29 million from the prior year quarter[7]. - Adjusted EBITDA for Q3 2025 was $42 million, down $9 million from the prior year quarter, with full year 2025 expected to be between $135 million and $140 million[6][32]. - RYAM's overall EBITDA for the full year 2025 is expected to approximate $227 million to $230 million, subject to additional impacts from tariffs[38]. - Gross margin for the three months ended September 27, 2025, was $34 million, down from $44 million in the same period last year, indicating a decline of 23%[63]. - The net loss attributable to Rayonier Advanced Materials Inc. for the nine months ended September 27, 2025, was $399 million, compared to a net loss of $23 million for the same period in 2024[63]. - Basic and diluted loss per share from continuing operations for the three months ended September 27, 2025, was $0.07, compared to a loss of $5.48 for the same period in 2024[63]. - For the nine months ended September 27, 2025, the total income from continuing operations attributable to RYAM was $110 million, down from $133 million in the same period last year[73]. - The company reported an adjusted free cash flow of $(83) million for the nine months ended September 27, 2025, compared to $99 million in the same period last year[76]. - EBITDA attributable to RYAM for the three months ended September 27, 2025, was $43 million, down from $66 million in the previous quarter[72]. Debt and Cash Flow - Total debt stood at $794 million with a net secured debt of $729 million, resulting in a covenant net secured leverage ratio of 4.1 times[6]. - Long-term debt increased to $764 million as of September 27, 2025, compared to $706 million at the end of 2024, marking an increase of 8%[65]. - Total debt increased to $794 million as of September 27, 2025, compared to $730 million on December 31, 2024, reflecting a rise of 8.8%[78]. - Adjusted Net Debt rose to $760 million from $653 million, indicating a significant increase of 16.4%[78]. - Cash and cash equivalents decreased to $(77) million from $(125) million, showing an improvement of 38.4%[78]. - Cash provided by operating activities for the nine months ended September 27, 2025, was a negative $8 million, a significant decrease from $149 million in the same period last year[67]. Sales and Market Performance - Cellulose Specialties net sales decreased by $28 million or 12% year-over-year, driven by a 17% decrease in sales volumes[9]. - Sales prices in the Cellulose Specialties segment are anticipated to be mid single-digit percentage above the prior year average, while sales volumes are expected to decline approximately 10%[37]. - Average sales price for Cellulose Specialties was $1,873 per metric ton for the three months ended September 27, 2025, up from $1,753 in the same period last year, indicating an increase of 7%[70]. - The sales volume of Cellulose Commodities for the three months ended September 27, 2025, was 93,000 metric tons, a decrease from 95,000 metric tons in the same period last year, representing a decline of 2%[70]. - Paperboard sales volumes are expected to remain soft, with an overall EBITDA expected to approximate $13 million for the full year 2025[44]. Strategic Initiatives - The company targets approximately $30 million in annual cost savings by 2026, with potential additional savings of up to $20 million in 2027[33]. - Biomaterials projects are expected to contribute approximately $31 million of run-rate proportional EBITDA by the end of 2027[33]. - The company aims to achieve over $300 million in run-rate EBITDA by the end of 2027, supported by strategic initiatives and pricing actions[4][33]. - The Company secured green capital of €67 million in Q4 2024 to advance its biomaterials strategy[39]. - RYAM is evaluating investments in crude tall oil facilities in Georgia and France, and has purchased high-quality CTO plant equipment for the Jesup project[45]. - The Company is pursuing a potential bioethanol facility in Florida, despite earlier site plan application denial, and remains confident in the project's merits[45]. - RYAM's production is being shifted toward non-fluff commodities due to disruptions in the global fluff market caused by Chinese retaliatory tariffs[41]. Expenses and Charges - Interest expense for Q3 2025 increased by $5 million compared to the prior year quarter, primarily due to a rise in the average effective interest rate on debt[26]. - Interest expense for the nine months ended September 27, 2025, was $70 million, an increase from $61 million in the same period last year[73]. - Corporate costs for the full year 2025 are expected to approximate $70 million, primarily due to non-cash environmental reserve charges[49]. - The company incurred indefinite suspension charges of $1 million in the three months ended September 27, 2025[72]. - Asset impairment charges were recorded at $25 million for the nine months ended September 27, 2025, consistent with the previous year[80]. - Indefinite suspension charges amounted to $1 million for the three months ended September 27, 2025, compared to $7 million in the same period in 2024[80]. - The total income tax expense for the nine months ended September 27, 2025, was $323 million, compared to an income tax benefit of $6 million in the same period last year[73].

Core Viewpoint - Rayonier Advanced Materials (NYSE: RYAM) is set to release its third quarter 2025 earnings on November 4, 2025, after market close, indicating a scheduled timeline for financial performance disclosure [1] Group 1 - The earnings release will be followed by a conference call and live webcast on November 5, 2025, at 9:00 a.m. ET to discuss the results [1] - Supplemental materials and access to the live audio webcast will be available on the company's website [1] - A replay of the webcast will be archived on the company's website shortly after the call [1]

Core Viewpoint - Rayonier Advanced Materials Inc. (RYAM) is set to discuss its first half 2025 performance and long-term growth milestones in an upcoming fireside chat with analyst Dmitry Silversteyn [1] Group 1 - The event will take place on September 22, 2025, featuring President and CEO De Lyle Bloomquist [1] - The discussion will focus on RYAM's performance and opportunities supporting the company's growth strategy [1]

Rayonier Advanced Materials (RYAM) FY Conference Summary Company Overview - Rayonier Advanced Materials operates in the natural cellulosic fibers industry, not merely as a pulp and paper company, but as a producer of specialty products including cellular specialty products and biomaterials [4][5][6] Core Business and Strategy - The company focuses on high purity specialty products and aims to grow its biomaterials segment, which is expected to provide significant growth potential and attractive returns to shareholders [5][6][9] - Rayonier operates four facilities located in the United States, Canada, and France, with a strategy centered on adding value through its core business and reducing costs [6][10] Financial Performance and Projections - The estimated EBITDA for 2025 is projected to be around $596 million, with a normalized EBITDA of approximately $200 million expected for 2026 [10][41] - The company faced a $21 million impact from tariffs, with $14 million related to U.S. customer sales affected by these tariffs [11][12] - Operational challenges included production losses due to strikes and severe weather, particularly affecting the Georgia facility [14][15] Market Dynamics - Rayonier is a leading producer in the cellular specialties market, controlling about 80% of the market share alongside two other major players [20][21] - The industry is experiencing high capacity utilization near 90%, with analysts projecting a 4-6% price increase, which is expected to outpace cost inflation [21][22] Growth Opportunities - The company plans to divest its non-core paperboard and high yield pulp businesses to focus on its cellular specialties and biomaterials segments [17][18] - There are significant opportunities in biomaterials, with projects aimed at monetizing the remaining 60% of wood used in production, which is currently burned for energy [29][30] - Projects include a bioethanol facility with a projected EBITDA of $8-10 million per year and a biomass electricity generator expected to generate $30 million in pretax income annually [31][36] Investment Outlook - Rayonier believes its current share price does not reflect the intrinsic value of its assets or growth potential, with projections suggesting a stock price increase to 8-10 times current levels based on future EBITDA multiples [41][42] - The company has a solid balance sheet and liquidity to fund growth projects without shareholder dilution, especially after divesting non-core businesses [39][40] Conclusion - Rayonier Advanced Materials presents a compelling investment opportunity with a strong focus on growth in high-margin specialty products and biomaterials, backed by a robust market position and strategic plans to enhance shareholder value [40][41]

Core Viewpoint - Rayonier Advanced Materials Inc. (RYAM) held its Q2 2025 earnings conference call, discussing financial performance and strategic direction [1][4]. Group 1: Financial Performance - The earnings report and presentation materials were released, providing insights into the company's financial performance [4]. - The call included discussions on non-GAAP financial measures to offer additional perspective on operational performance [5]. Group 2: Leadership and Participation - The conference call featured key company participants including De Lyle Bloomquist (President and CEO) and Marcus Moeltner (CFO and Senior VP of Finance) [3]. - Michael H. Walsh (VP of Investor Relations and Treasurer) hosted the call, welcoming participants and outlining the agenda [2][3].

Financial Data and Key Metrics Changes - In Q2 2025, revenue was $340 million, down $79 million year-over-year. Operating loss was $1 million, a decline of $29 million compared to the prior year. Adjusted EBITDA was $28 million, a decrease of $40 million year-over-year [35][36][37] - Full year 2025 adjusted EBITDA guidance was revised to a range of $150 million to $160 million, implying second half EBITDA of approximately $105 million to $115 million [37] Business Line Data and Key Metrics Changes - In the cellulose specialties segment, net sales decreased by $33 million to $208 million, with a 3% increase in sales prices offset by a 15% decline in sales volumes. Operating income declined by $21 million year-over-year to $29 million [38] - The biomaterials segment saw net sales decline by $2 million year-over-year to $6 million, with adjusted EBITDA margin dropping to 17% from 25% in the prior year [39] - The paperboard segment's net sales decreased by $13 million year-over-year to $47 million, reflecting a 23% decline in sales volumes and a 3% decrease in prices [40] - The high yield pulp segment experienced a net sales decrease of $4 million year-over-year to $29 million, driven by an 11% decline in sales prices [41] Market Data and Key Metrics Changes - The company faced approximately $59 million in EBITDA headwinds in 2025, primarily from tariff-related uncertainty, foreign exchange losses, operational disruptions, and noncash environmental charges [6][7][8] - The cellulose specialty market is expected to grow, with industry analysts forecasting sustained annual price increases of approximately 4% to 6% [19] Company Strategy and Development Direction - The company plans to nearly double its EBITDA over the next two years, focusing on accelerating revenue growth, expanding margins, and achieving exceptional returns on strategic growth investments [5][6] - A divestiture of non-core paperboard and high yield pulp businesses is anticipated, transforming the company into a more focused entity on core businesses [17][18] - The company aims to capture market share growth opportunities in the cellulose specialties market, leveraging its excess capacity [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that the extraordinary challenges faced in 2025 are largely behind them, with expectations for accelerating growth and profitability in subsequent quarters [6][8] - The company highlighted a strong liquidity position of approximately $202 million, including $71 million in cash, which supports its strategic initiatives without shareholder dilution [31] Other Important Information - The company is targeting around $10 million in corporate expense reductions and anticipates $20 million in operational savings from various initiatives [21] - The biomaterials initiative is expected to generate significant cash flows from high-value products, with a projected annual EBITDA contribution of $8 million to $10 million from the Tardis bioethanol project [25][26] Q&A Session Summary Question: Timeline for dissolving wood pulp fluff product approval for sale in China - Management indicated that trials are ongoing, and if successful, commercialization is expected as they approach 2026 [43][44] Question: Structural cost reduction initiatives and timing of execution at Temiscaming - Most of the $24 million capital for cost savings will be spent in 2025, with expected realization of $30 million in savings in 2026 [47][49] Question: Incremental EBITDA within cellulose specialties and capital deployment in 2027 - The $30 million growth is tied to the substitution of cellulose specialties for commodities, with a focus on high-return projects for capital deployment [56][64] Question: Confidence in ramping up biomaterials business and market share - Management expressed high confidence in ramping up construction and commercialization of biomaterials projects, with commercial agreements in place to support market entry [83][84]

Financial Performance & Challenges - RYAM reported Q2 2025 revenue of $340 million, a decrease of $79 million compared to Q2 2024[59] - The company's Adjusted EBITDA for Q2 2025 was $28 million, down $40 million from Q2 2024[59] - RYAM faces an Adjusted Free Cash Flow deficit of $(52) million year-to-date[59] - The company's 2025 EBITDA guidance is projected to be in the range of $150 million to $160 million[14, 59] Segment Performance - Cellulose Specialties reported Q2 2025 sales of $208 million with an Adjusted EBITDA of $46 million, representing a 22% margin[60] - Cellulose Commodities experienced a negative Adjusted EBITDA of $(2) million on sales of $59 million, with a margin of (3%)[69] - Paperboard sales were $47 million with an Adjusted EBITDA of $5 million, resulting in an 11% margin[75] - High-Yield Pulp reported sales of $29 million and a negative Adjusted EBITDA of $(7) million, with a margin of (24%)[80] Strategic Initiatives & Outlook - RYAM aims to restore Temiscaming's profitability, targeting a $35 million improvement and positioning it for potential divestiture in 2026[22] - The company anticipates a 2027 run-rate EBITDA of $308 million for its core business, excluding the AGE project[26] - RYAM expects to generate approximately $30 million of cumulative incremental EBITDA by 2027 by capturing Cellulose Specialties market growth[35] - BioNova is expected to invest $110 million to generate ~$39 million in EBITDA, implying a build multiple of 28X[41]

Core Viewpoint - Rayonier Advanced Materials reported a quarterly loss of $0.43 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.20, marking an earnings surprise of -115.00% [1] - The company has struggled with revenue, posting $340 million for the quarter, which is a 15.9% miss compared to the consensus estimate and a decline from $419 million year-over-year [2] Group 1: Financial Performance - The company has not surpassed consensus revenue estimates over the last four quarters, indicating ongoing challenges in meeting market expectations [2] - Rayonier Advanced Materials shares have declined approximately 54.8% year-to-date, contrasting sharply with the S&P 500's gain of 7.6% [3] Group 2: Future Outlook - The future performance of Rayonier Advanced Materials will largely depend on management's commentary during the earnings call and the subsequent revisions of earnings estimates [4][6] - The current consensus EPS estimate for the upcoming quarter is $0.08 on revenues of $410.7 million, while for the current fiscal year, the estimate is -$0.46 on revenues of $1.59 billion [7] Group 3: Industry Context - The Paper and Related Products industry, to which Rayonier Advanced Materials belongs, is currently ranked in the bottom 15% of over 250 Zacks industries, which may negatively impact the stock's performance [8]

Second Quarter 2025 Performance Highlights The company's Q2 results were significantly impacted by extraordinary and largely non-recurring challenges, including tariff volatility, operational disruptions, and a major non-cash deferred tax asset write-off - The company's Q2 results were significantly impacted by extraordinary and largely non-recurring challenges, including tariff volatility, operational disruptions, and a major non-cash deferred tax asset write-off[2](index=2&type=chunk)[4](index=4&type=chunk) Q2 2025 Key Financial Metrics | Metric | Value (in millions) | | :--- | :--- | | Net Sales | $340 | | Loss from Continuing Operations | $366 | | Adjusted EBITDA from Continuing Operations | $28 | | Total Debt | $746 | | Net Secured Debt | $688 | Revised 2025 Full Year Guidance | Metric | Guidance Range (in millions) | | :--- | :--- | | Adjusted EBITDA | $150 to $160 | | Adjusted Free Cash Flow | $(10) to $(25) | - Despite short-term headwinds, the company's long-term plan remains on track to deliver over **$300 million** in run-rate EBITDA by the end of 2027[3](index=3&type=chunk)[4](index=4&type=chunk) [Financial Results](index=2&type=section&id=Financial%20Results) The company experienced a significant Q2 2025 financial downturn, marked by decreased sales, operating losses, and a substantial non-cash tax write-off [Overall Financial Results](index=2&type=section&id=Overall%20Financial%20Results) Q2 2025 net sales decreased 19% to **$340 million**, leading to an operating loss and a **$366 million** loss from continuing operations, primarily due to a non-cash tax write-off Net Sales by Segment (in millions) | Segment | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Cellulose Specialties | $208 | $201 | $241 | | Biomaterials | $6 | $7 | $8 | | Cellulose Commodities | $59 | $75 | $85 | | Paperboard | $47 | $49 | $60 | | High-Yield Pulp | $29 | $31 | $33 | | **Total Net Sales** | **$340** | **$356** | **$419** | Operating Income (Loss) by Segment (in millions) | Segment | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Cellulose Specialties | $29 | $31 | $50 | | Biomaterials | $1 | $2 | $1 | | Cellulose Commodities | $(9) | $(13) | $(21) | | Paperboard | $— | $(2) | $12 | | High-Yield Pulp | $(7) | $(7) | $1 | | Corporate | $(15) | $(26) | $(15) | | **Total Operating Income (Loss)** | **$(1)** | **$(15)** | **$28** | Q2 2025 vs. Q2 2024 Profitability Comparison | Metric | Q2 2025 | Q2 2024 | | :--- | :--- | :--- | | Net Income (Loss) | $(363) million | $11 million | | Diluted EPS | $(5.44) | $0.17 | | Loss from Continuing Operations | $(366) million | $8 million income | [Segment Performance Analysis](index=2&type=section&id=Segment%20Performance%20Analysis) Most segments experienced year-over-year declines in performance, with Cellulose Specialties, Paperboard, and High-Yield Pulp facing significant operating income drops or losses [Cellulose Specialties](index=2&type=section&id=Cellulose%20Specialties) Net sales decreased **14%** to **$208 million** due to a **15%** volume decline from tariff uncertainty and a labor strike, leading to a **42%** drop in operating income - Sales volumes decreased **15%** YoY, primarily due to a pause in customer orders driven by tariff uncertainty, strong sales in the prior year quarter, and a labor strike at the Tartas plant[8](index=8&type=chunk) - Operating income decreased by **$21 million** (**42%**) compared to the prior year quarter, driven by lower sales volumes, higher key input costs, and lower production from operational challenges[9](index=9&type=chunk) [Biomaterials](index=4&type=section&id=Biomaterials) Net sales declined **25%** to **$6 million** due to production issues and raw material supply constraints from a labor strike, while operating income remained flat at **$1 million** - The sales decrease was driven by lower production due to operational challenges and the impact of the labor strike at the Tartas cellulose plant, which limited feedstock for the bioethanol facility[11](index=11&type=chunk) - Operating income was flat YoY as higher shared service costs were offset by lower production costs resulting from reduced feedstock availability[12](index=12&type=chunk) [Cellulose Commodities](index=4&type=section&id=Cellulose%20Commodities) Net sales declined **31%** to **$59 million** on a **33%** volume drop, yet the operating loss improved **57%** to **$9 million** due to lower non-fluff commodity losses - Sales volumes decreased **33%** YoY due to lower non-fluff commodity sales and a labor strike, partially offset by a **7%** increase in sales prices for fluff[13](index=13&type=chunk) - The operating loss improved by **$12 million** (**57%**) YoY, driven by lower non-fluff commodity losses, lower indefinite suspension charges, and lower key input costs[14](index=14&type=chunk) [Paperboard](index=4&type=section&id=Paperboard) Net sales decreased **22%** to **$47 million** with volumes down **23%** due to tariffs and competition, resulting in a **$12 million** decline in operating results to breakeven - Sales volumes and prices decreased **23%** and **3%** respectively, driven by tariff uncertainty and increased competitive activity from EU imports and new U.S. capacity[16](index=16&type=chunk) - Operating results declined by **$12 million** (**100%**) YoY, driven by lower sales and the impact of net custodial site costs from the suspended Temiscaming operations[17](index=17&type=chunk) [High-Yield Pulp](index=4&type=section&id=High-Yield%20Pulp) Net sales fell **12%** to **$29 million** due to weak demand and oversupply, causing the segment to swing from a **$1 million** operating income to a **$7 million** loss - Sales prices and volumes decreased due to lower demand, particularly in China, continued oversupply, and the timing of shipments[19](index=19&type=chunk) - Operating results declined by **$8 million** YoY, driven by lower sales, higher logistics costs, and the impact of Temiscaming net custodial site costs[20](index=20&type=chunk) [Corporate and Other Items](index=5&type=section&id=Corporate%20and%20Other%20Items) Corporate operating loss remained flat at **$15 million**, while a significant **$337 million** non-cash tax expense was recognized due to a valuation allowance on Canadian deferred tax assets - Corporate operating loss was flat YoY as lower variable compensation and ERP implementation costs were offset by unfavorable foreign exchange rates[21](index=21&type=chunk) - A valuation allowance was required against Canadian deferred tax assets, resulting in a non-cash tax expense of **$337 million** in the quarter[24](index=24&type=chunk) - Interest expense increased by **$2 million** YoY due to a higher average effective interest rate on debt[23](index=23&type=chunk) [Cash Flow and Liquidity](index=5&type=section&id=Cash%20Flow%20and%20Liquidity) The company generated **$10 million** in operating cash flow for the first half of 2025, ending Q2 with **$202 million** in global liquidity and a **3.8x** net secured leverage ratio Cash Flow Summary (Six Months Ended June 28, 2025) | Metric | Value (in millions) | | :--- | :--- | | Cash Provided by Operating Activities | $10 | | Cash Used in Investing Activities | $(75) | | Cash Provided by Financing Activities | $1 | - The company ended Q2 with **$202 million** of global liquidity, comprising **$71 million** of cash, **$116 million** of borrowing capacity under the ABL Credit Facility, and **$15 million** under a France factoring facility[29](index=29&type=chunk) - As of June 28, 2025, the company's consolidated net secured leverage ratio was **3.8 times** covenant EBITDA[30](index=30&type=chunk) [Business Outlook](index=6&type=section&id=Business%20Outlook) The company revised its 2025 Adjusted EBITDA guidance downward due to H1 challenges, while maintaining its long-term EBITDA growth strategy [Overall 2025 Outlook](index=6&type=section&id=Overall%202025%20Outlook) The company revised its full-year 2025 Adjusted EBITDA guidance to **$150 million to $160 million** due to H1 challenges, while its long-term EBITDA target of over **$300 million** by 2027 remains Full Year 2025 Guidance | Metric | Guidance Range (in millions) | | :--- | :--- | | Adjusted EBITDA | $150 to $160 | | Loss from continuing operations | $(75) to $(65) | - The company expects to meaningfully grow EBITDA over the two years following 2025, targeting over **$300 million** in run-rate EBITDA by the end of 2027[33](index=33&type=chunk) - The process to explore the sale of its Paperboard and High-Yield Pulp businesses is now effectively on hold due to current market conditions and trade-related uncertainty[34](index=34&type=chunk) [Segment Outlook for 2025](index=6&type=section&id=Segment%20Outlook%20for%202025) For 2025, Cellulose Specialties is expected to lead in EBITDA, while Cellulose Commodities and High-Yield Pulp anticipate losses, with Paperboard and Biomaterials contributing positively [Cellulose Specialties Outlook](index=6&type=section&id=Cellulose%20Specialties%20Outlook) Full-year 2025 sales prices are expected to increase mid-single-digit, volumes to decline high-single-digit, with EBITDA projected between **$232 million** and **$235 million** - Sales prices are expected to increase by a **mid single-digit percentage**, while sales volumes are anticipated to decline by a **high single-digit percentage** in 2025[35](index=35&type=chunk) - Full year 2025 EBITDA is expected to be approximately **$232 million to $235 million**[36](index=36&type=chunk) [Biomaterials Outlook](index=6&type=section&id=Biomaterials%20Outlook) The company is advancing its biomaterials strategy, targeting over **$70 million** in long-term EBITDA, with **$8 million to $10 million** projected for full-year 2025 - The company is pursuing investments in bioethanol, lignosulfonate, crude tall oil, and prebiotics, with a long-term goal of generating over **$70 million** of EBITDA from the Biomaterials business[37](index=37&type=chunk) - Full year 2025 EBITDA is expected to be approximately **$8 million to $10 million**[38](index=38&type=chunk) [Cellulose Commodities Outlook](index=7&type=section&id=Cellulose%20Commodities%20Outlook) Facing Chinese tariffs, the segment is shifting production to non-fluff commodities, with an expected full-year 2025 EBITDA loss of approximately **$15 million** - Production is being actively shifted toward non-fluff commodities until the new DWP fluff product is fully qualified in China, mitigating the impact of tariffs[39](index=39&type=chunk) - Full year 2025 EBITDA is expected to be a loss of approximately **$15 million**[40](index=40&type=chunk) [Paperboard Outlook](index=7&type=section&id=Paperboard%20Outlook) Due to soft volumes and declining prices, Paperboard production will be idled for two weeks in Q3, with full-year 2025 EBITDA expected at approximately **$20 million** - The company is idling Paperboard production for two weeks during Q3 to align inventory levels with demand[41](index=41&type=chunk) - Full year 2025 EBITDA is expected to be approximately **$20 million**[42](index=42&type=chunk) [High-Yield Pulp Outlook](index=7&type=section&id=High-Yield%20Pulp%20Outlook) Due to oversupply in China, prices and volumes are expected to decline, leading to a three-week production idle in Q3 and a projected full-year EBITDA loss of **$20 million to $25 million** - The company is idling High-Yield Pulp production for three weeks during Q3 to proactively manage inventory levels[43](index=43&type=chunk) - Full year 2025 EBITDA is expected to be a loss of **$20 million to $25 million**[44](index=44&type=chunk) [Corporate Outlook](index=7&type=section&id=Corporate%20Outlook) Full-year 2025 Corporate costs are projected at approximately **$70 million**, an increase primarily due to a **$12 million** non-cash environmental charge and potential foreign exchange headwinds - Full year 2025 Corporate costs are expected to be approximately **$70 million**, higher than prior year due to a **$12 million** non-cash environmental charge and potential FX headwinds[45](index=45&type=chunk)[46](index=46&type=chunk) [Financial Statements and Non-GAAP Reconciliations](index=10&type=section&id=Financial%20Statements%20and%20Non-GAAP%20Reconciliations) This section provides the unaudited consolidated financial statements and detailed reconciliations of non-GAAP financial measures to their GAAP equivalents [Consolidated Financial Statements](index=10&type=section&id=Consolidated%20Financial%20Statements) The unaudited condensed consolidated financial statements present a **$395 million** net loss for the six months ended June 28, 2025, with total assets decreasing from **$2.13 billion** to **$1.76 billion** - The Condensed Consolidated Statements of Operations for the three and six months ended June 28, 2025 are provided[59](index=59&type=chunk)[60](index=60&type=chunk) - The Condensed Consolidated Balance Sheets as of June 28, 2025, and December 31, 2024, are provided[61](index=61&type=chunk)[62](index=62&type=chunk) - The Condensed Consolidated Statements of Cash Flows for the six months ended June 28, 2025, are provided[63](index=63&type=chunk)[64](index=64&type=chunk) [Key Operating Metrics](index=13&type=section&id=Key%20Operating%20Metrics) This section details average sales prices per metric ton and sales volumes in thousands of metric tons for each business segment across comparative periods - A detailed breakdown of Average Sales Prices (**$ per metric ton**) and Sales Volumes (**'000s of metric tons**) for each segment is available for comparative quarterly and six-month periods[66](index=66&type=chunk)[67](index=67&type=chunk) [Non-GAAP Reconciliations](index=14&type=section&id=Non-GAAP%20Reconciliations) This section provides detailed reconciliations of non-GAAP financial measures, including EBITDA, Adjusted Free Cash Flow, and Net Secured Debt, to their comparable GAAP measures - Reconciliation of Income (Loss) from continuing operations to EBITDA and Adjusted EBITDA is provided by segment for the three and six-month periods, along with the 2025 annual guidance reconciliation[68](index=68&type=chunk)[69](index=69&type=chunk)[70](index=70&type=chunk) - Reconciliation of cash provided by operating activities to Adjusted Free Cash Flow is provided for the six-month period and for the 2025 annual guidance[72](index=72&type=chunk)[73](index=73&type=chunk) - Reconciliation of total debt to Adjusted Net Debt and Net Secured Debt is provided as of June 28, 2025[75](index=75&type=chunk)[76](index=76&type=chunk)